INTELLIGENT BIO SOLUTIONS INC. Deferred Income
INTELLIGENT BIO SOLUTIONS INC. (INBS) had Deferred Income of $179.26 thousand as of 2022-03-31, per its 10-Q filed 2022-05-16.
Financial Statements › Balance Sheet › Liabilities
us-gaap:DeferredIncome · last filed 2026-08-19
- 2022-03-31: Deferred Income $179.26K.
- 2021-06-30: Deferred Income $4.70M; Deferred Income as first filed $5.24M.
| Period end | Deferred Income | Deferred Income as first filed |
|---|---|---|
| 2022-03-31 | $179.26K 10-Q · filed 2022-05-16 | |
| 2021-06-30 | $4.70M 10-K · filed 2026-08-19 | $5.24M 10-K · filed 2021-09-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |